(A) Under normal conditions, an inflammatory stimulus (for example, proinflammatory cytokines or mechanical trauma) initiates a signal cascade (1) that leads to the activation of cPLA2α and its translocation to intracellular membranes, such as the Golgi apparatus, where it binds to C1P (2). There, cPLA2α preferentially cleaves arachidonic acid–containing phospholipids at the sn-2 position, releasing free fatty acids (3). Free arachidonic acid can be converted by intracellular enzymes such as COX-1 and COX-2 (4) into PGE2 through a multi-step process (5). (B) When cPLA2α cannot bind to C1P, agonist-mediated signaling (1) leads to the activation of cPLA2α and its translocation to intracellular lipid droplets, where it binds to PIP2 (2). There, cPLA2α preferentially cleaves arachidonic acid–containing phospholipids, releasing free fatty acids (3). Free arachidonic acid binds to 5-LO (4), which interacts with FLAP at lipid droplets (4) instead of at the nucleus. FLAP-mediated activation of 5-LO enzymatic activity stimulates the production of 5-HETE, leading to a 5-HETE–dominated eicosanoid profile.